CBP ruling NY N361037
The tariff classification and country of origin of Naltrexone Hydrochloride Tablets in dosage form
No Headquarters ruling in this index revokes or modifies this ruling. That is not confirmation that it is still in effect: this index does not hold every Headquarters ruling. Confirm its current status with CBP before relying on it (ruling on CBP CROSS). Text last read from CBP on Nov 21, 2026.
Ruling text
Read the full ruling on CBP CROSS (N361037).